Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus.


Journal

Cellular signalling
ISSN: 1873-3913
Titre abrégé: Cell Signal
Pays: England
ID NLM: 8904683

Informations de publication

Date de publication:
06 2019
Historique:
received: 16 08 2018
revised: 28 02 2019
accepted: 01 03 2019
pubmed: 7 3 2019
medline: 18 7 2020
entrez: 7 3 2019
Statut: ppublish

Résumé

There is evidence that B cells from patients with Systemic Lupus Erythematosus (SLE) could be hyperactivated due to changes in their lipid rafts (LR) composition, leading to altered BCR-dependent signals. This study aimed to characterize possible alterations in the recruitment of protein tyrosine kinases (PTK) into B cells LR from SLE patients. Fifteen patients with SLE and ten healthy controls were included. Circulating B cells were isolated by negative selection and stimulated with goat Fab´2 anti-human IgM/IgG. LR were isolated with a non-ionic detergent and ultracentrifuged on 5-45% discontinuous sucrose gradients. Proteins from each fraction were analyzed by Western Blot. Total levels of Lyn, Syk, and ZAP-70 in resting B cells were similar in SLE patients and healthy controls. Upon BCR activation, Lyn, Syk and ZAP-70 recruitment into LR increased significantly in B cells of healthy controls and patients with inactive SLE. In contrast, in active SLE patients there was a great heterogeneity in the recruitment of signaling molecules and the recruitment of ZAP-70 was mainly observed in patients with decreased Syk recruitment into LR of activated B cells. The reduction in Flotilin-1 and Lyn recruitment in SLE patients seem to be associated with disease activity. These findings suggest that in SLE patients the PTK recruitment into B cell LR is dysregulated and that B cells are under constant activation through BCR signaling. The decrease of Lyn and Syk, the expression of ZAP-70 by B cells and the increase in Calcium fluxes in response to BCR stimulation in active SLE patients, further support that B cells from SLE patients are under constant activation through BCR signaling, as has been proposed.

Identifiants

pubmed: 30840855
pii: S0898-6568(19)30046-4
doi: 10.1016/j.cellsig.2019.03.003
pii:
doi:

Substances chimiques

SYK protein, human EC 2.7.10.2
Syk Kinase EC 2.7.10.2
ZAP-70 Protein-Tyrosine Kinase EC 2.7.10.2
ZAP70 protein, human EC 2.7.10.2
lyn protein-tyrosine kinase EC 2.7.10.2
src-Family Kinases EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-19

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ana Vásquez (A)

Grupo de Inmunología Celular e Inmunogenética (GICIG), Sede de investigación Universitaria (SIU), Facultad de Medicina, Universidad de Antioquia, Carrera 53, # 61-30, Medellín, Colombia.

Andrés Baena (A)

Grupo de Inmunología Celular e Inmunogenética (GICIG), Sede de investigación Universitaria (SIU), Facultad de Medicina, Universidad de Antioquia, Carrera 53, # 61-30, Medellín, Colombia.

Luis A González (LA)

Grupo de Reumatología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Mauricio Restrepo (M)

Grupo de Reumatología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Carlos H Muñoz (CH)

Grupo de Reumatología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Sección Reumatología, Hospital Universitario San Vicente Fundación, Medellín, Colombia.

Adriana Vanegas-García (A)

Grupo de Reumatología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Sección Reumatología, Hospital Universitario San Vicente Fundación, Medellín, Colombia.

Blanca Ortiz-Reyes (B)

Grupo de Inmunología Celular e Inmunogenética (GICIG), Sede de investigación Universitaria (SIU), Facultad de Medicina, Universidad de Antioquia, Carrera 53, # 61-30, Medellín, Colombia.

Nursamaa Abdoel (N)

Centro Nacional de Enfermedades Reumáticas, Hospital Universitario de Caracas, Carcas, Venezuela.

Mauricio Rojas (M)

Grupo de Inmunología Celular e Inmunogenética (GICIG), Sede de investigación Universitaria (SIU), Facultad de Medicina, Universidad de Antioquia, Carrera 53, # 61-30, Medellín, Colombia; Unidad de Citometria, Universidad de Antioquia, Colombia.

Luis F García (LF)

Grupo de Inmunología Celular e Inmunogenética (GICIG), Sede de investigación Universitaria (SIU), Facultad de Medicina, Universidad de Antioquia, Carrera 53, # 61-30, Medellín, Colombia.

Gloria Vásquez (G)

Grupo de Inmunología Celular e Inmunogenética (GICIG), Sede de investigación Universitaria (SIU), Facultad de Medicina, Universidad de Antioquia, Carrera 53, # 61-30, Medellín, Colombia; Grupo de Reumatología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. Electronic address: gloria.vasquez@udea.edu.co.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH